A nurse is planning education for a client who is prescribed heparin. Which statement should the nurse plan to include in the teaching?

A. Red blood cells: While red blood cell counts provide information about oxygen-carrying capacity and anemia, they do not directly reflect the anticoagulant effect of heparin or the risk of bleeding due to its use. Monitoring RBCs is not sufficient for safe heparin therapy.

B. International normalized ratio (INR): INR is primarily used to monitor warfarin therapy, not heparin. It measures the extrinsic pathway of coagulation, whereas heparin affects the intrinsic pathway, so INR is not the appropriate laboratory value for heparin monitoring.

C. Partial thromboplastin time (PTT): PTT measures the effectiveness of the intrinsic and common coagulation pathways, which are directly affected by heparin. Monitoring PTT helps ensure that the client maintains a therapeutic anticoagulation range and reduces the risk of bleeding or clot formation.

D. Hematocrit: Hematocrit reflects the proportion of red blood cells in the blood and can indicate blood loss over time. While important for general assessment, it does not specifically monitor heparin’s anticoagulant effect and is not the primary lab value to guide dosing.

A. "Heparin will help prevent the development of a blood clot.": Heparin is an anticoagulant that works by inhibiting clotting factors, reducing the risk of new clot formation. It does not dissolve existing clots but is essential in preventing progression or formation of additional thrombi.

B. "Heparin will help to stabilize your blood pressure and heart rate.": Heparin does not have effects on cardiovascular parameters such as blood pressure or heart rate. Monitoring vital signs is important during therapy, but the medication’s purpose is anticoagulation, not hemodynamic stabilization.

C. "Heparin will help to break down the existing clot in your leg.": Heparin prevents further clot formation but does not actively dissolve existing thrombi. Thrombolytic medications, not heparin, are used for clot breakdown.

D. "Heparin will help increase the number of platelets in the body.": Heparin can actually decrease platelet count in some cases (heparin-induced thrombocytopenia), so it does not increase platelet levels. Its mechanism is anticoagulation through inhibition of clotting factors, not platelet production.